EDGAR·FLOW

Viridian Therapeutics, Inc.\DE — Form 10-Q

Filed November 4, 2026 · analyzed by the Periodic Agent
10-Q — Neutral significance 28/100
What the filing says
Viridian Therapeutics signed a Seventh Amendment to its Waltham, MA lease (Landlord: Watch City Ventures MT LLC) effective September 25, 2026, adding ~12,167 rentable sq ft (Suite 403 Premises) on the 4th floor of Buildings #4, #21, #25. Base rent starts at $44.00/RSF ($535,348 annually) with 3% annual increases through July 2029; rent commences October 1, 2026 (or upon delivery, whichever is later), with rent abated for months 1, 2, and 4. Viridian receives a tenant improvement allowance for paint and carpet work, a right of first refusal on additional 4th-floor space, 102 parking spaces, and extends its existing lease through July 2029 plus one 3-year renewal option. Total premises now ~30,722 sq ft; Viridian's proportionate share increases to 19.92% of the complex.
Why this rating

Real estate expansion of ~$6.8M over 3 years is ~0.7% of $943M market cap—a small operational adjustment. No material business impact.

View original filing on SEC.gov ↗ VRDN · stock on Yahoo Finance ↗

See more from November 4, 2026.

EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.